The Rockville-based startup will use the money to support a phase 2 clinical trial for its glioblastoma therapy and also is working on a COVID-19 vaccine, according to the Washington Business Journal.
The Center for Mobile Technologies to Achieve Equity in Cardiovascular Health at The Johns Hopkins University will receive $2.5 million to help create the AHA’s Strategically Focused Research Network on Health Technologies and Innovation. Johns Hopkins researchers will develop and test a smartphone application for stroke diagnosis, and also will work on a virtual cardiovascular rehab that builds on Corrie Health’s platform to empower patients in guideline-based prevention.
The Social Innovation Lab alum, which simplifies the way patients seek and receive mental-health care, is in the midst of a $1.5 million raising round and has made its program free in response to the coronavirus pandemic.
Hanes, founder of Kala Pharmaceuticals and GrayBug Vision, was cited in the biopharmaceuticals category. He is the director of the Center for Nanomedicine and Lewis J. Ort Professor of Ophthalmology at the Wilmer Eye Institute at Johns Hopkins.
Bailey previously served as chief commercial officer of the Baltimore-based startup after spending 14 years at Roche. PGDx has more than 200 employees.
The startup, which is developing next-generation synthetic soft tissues for reconstructive and aesthetic surgical procedures, will use the money to support clinical development of its products.